SOPHIA WOODSON: Open Payments
NPI 1023161098 · CLEVELAND, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$11,242 in 78 payments from 17 companies in 2025. Trend: 2023 $10,994 · 2024 $17,209 · 2025 $11,242
Consulting: $8,071Food & beverage: $2,641Travel & lodging: $501Education: $29
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 10 | $6,084 |
| Biogen, Inc. | 12 | $3,390 |
| Novartis Pharmaceuticals Corporation | 17 | $402 |
| EMD Serono, Inc. | 6 | $321 |
| Genentech USA, Inc. | 11 | $220 |
| TG Therapeutics, Inc. | 2 | $191 |
| Amgen Inc. | 5 | $190 |
| Genentech, Inc. | 2 | $125 |
| Alexion Pharmaceuticals, Inc. | 4 | $117 |
| Celgene Corporation | 2 | $46 |
Products named: KESIMPTA, TYSABRI, BRIUMVI, UPLIZNA, Ocrevus Zunovo, Ocrevus, ULTOMIRIS, ZEPOSIA.
Industry payments across OH — which companies pay providers there.
